Delivra Health Brands (DHB) Investor Update summary

Company structure and brand portfolio

• Operates three major brands: LivRelief (plant-based pain relief), Dream Water (sleep aids), and LivRelief Infuse (regulated Canadian market).

• Focuses on natural wellness products with high consumer retention and unique patented formulations.

• Asset-light manufacturing and supply chain model reduces overhead and supports margin improvement.

Strategic turnaround and financial performance

• Executed a responsible turnaround since 2020, moving from high debt, negative EBITDA, and high SG&A to positive EBITDA and improved margins.

• Gross profit margin increased from 9% in 2020 to 52% in 2024, with SG&A expenses reduced from $12M to $5.7M.

• EBITDA improved from negative $9M to positive $871K as of June 2024.

• Revenue and net revenue have shown consistent growth over the past four years.

Market position and growth strategy

• Holds approximately 60% market share in the sleep category within North American airports for Dream Water.

• LivRelief is a top producer in Canada for all-natural plant-based pain relief, competing with major brands.

• Expanding distribution in grocery, convenience, and drug channels, with plans for global growth.

• Utilizes a combination of direct sales force and broker network to drive channel and geographic expansion.